Workshops
-
Activities
Workshops
Translation from Research to Policy: A focus on a global diabetes agenda
Summary: The aim of workshop was to bring together a wide range of stakeholders to have an open- forum and use the collective intelligence in the room to provide concrete recommendations on how to improve national and international science-policy ecosystems.
“Policy making is messy and other stakeholders need to realize this and manage this..“ Rafael Bengoa, Former Minister for Health. Basque Government; Former Director Health Systems WHO, Spain.
Organisers: University of Geneva, Division of Tropical and Humanitarian Medicine, NCD Policy Lab, Geneva Science-Policy Interface
Ethical, economic, health system and person factors in the introduction of screening and high-priced medicines for NCDs: The example of Teplizumab for type 1 diabetes
Although screening for type 1 diabetes has been available for quite some time, until recently no therapeutic solutions were available for people identified at risk of developing this condition. The advent of Teplizumab marks a milestone for type 1 diabetes, however different factors need to be explored in order to develop appropriate responses as we transition from research settings for screening and the use of Teplizumab to implementation within health systems.
During the workshop a variety of issues were explored. First and foremost, the issue of screening and type 1 diabetes in the context of now having a disease modifying medicine. The workshop participants also explored the pros and cons of screening and Teplizumab and identified cross-cutting themes that need to be addressed when thinking about its introduction.
Workshop on cross-cutting advocacy priorities for access to NCD medicines, diagnostics and medical devices
Driving coherence between technical expertise and advocay at a global and national levels for NCDs
On 27 November, the NCD Policy Lab partnered with the NCD Alliance to convene a targeted workshop dedicated to advancing access to essential NCD medicines, diagnostics, and medical devices.
This session brought together experts from the World Health Organization, global access initiatives, civil-society organisations, and private-sector partners, creating a valuable forum to align priorities and identify concrete pathways forward. The workshop built on the momentum generated during last June’s Hackccess Hackathon, highlighting both the progress achieved and the innovative solutions now taking shape.
Stay tuned for the next steps in developing a coordinated advocacy plan and advancing efforts to improve access to these essential medicines, diagnostics, and medical devices.
Organisers: NCD Policy Lab, University of Geneva, NCD Alliance